Nitazoxanide in Acute Rotavirus Diarrhea: A Randomized Control Trial from a Developing Country

Table 1

Baseline and demographic characteristics of the study population.

	Nitazoxanide group	Control group	value
Age, months (IQR)	26 (8.7)	25 (8.3)	0.38
Males (%)	16 (64)	17 (68)	0.76
Weight (kg) (IQR)	11.3 (2.2)	11.1 (2.8)	0.28
Median duration (IQR) of diarrhea before treatment (hours)	42 (13)	45 (11)	0.35
Stool consistency at the time of enrolment (%)
Liquid	11 (44)	10 (40)	0.24
Semiliquid	05 (20)	07 (28)
Loose	09 (36)	08 (32)
Number (%) of children vomiting	13 (52)	11 (44)	0.57
Median (IQR) duration of vomiting (hours)	28 (13)	30 (12)	0.4
Number (%) of children with fever	09 (36)	07 (28)	0.55
Median (IQR) duration of fever (hours)	30 (16)	33 (15)	0.47
Dehydration status (%)
Mild	08 (32)	09 (36)	0.65
Moderate	13 (52)	11 (44)

IQR: Interquartile range.